Original Article from The New England Journal of Medicine — Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Source: Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes — NEJM
Original Article from The New England Journal of Medicine — Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Source: Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes — NEJM